TG Therapeutics (TGTX) Exercises Option to Globally License TGR-1202
Tweet Send to a Friend
TG Therapeutics (Nasdaq: TGTX) announced that it has exercised its option to license the global rights to TGR-1202, the Company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
